載入...
T cell-NF-κB activation is required for tumor control in vivo
BACKGROUND: T cells have the capacity to eliminate tumors but the signaling pathways by which they do so are incompletely understood. T cell priming requires activation of the transcription factors AP-1, NFAT and NF-κB downstream of the TCR, but whether activation of T cell-NF-κB in vivo is required...
Na minha lista:
| 發表在: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4308877/ https://ncbi.nlm.nih.gov/pubmed/25648675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-014-0045-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|